Home
Sunshine Guojian Pharmaceutical Shanghai

Sunshine Guojian Pharmac... Market Share Analysis for June 2026

三生国健是一家专注于抗体药物的创新型生物医药企业，也是一家具备自主研发、产业化及商业化能力的高新技术企业。公司致力于以创新型治疗性抗体药物为主要研发方向，为包括自身免疫性疾病、肿瘤等重大疾病治疗领域提供高品质、安全有效的临床解决方案。

Industry: N/A

Domain3s-guojian.com

Year Founded--

Employees501 - 1000

Annual Revenue--

Sunshine Guojian Pharmaceutical Shanghai

Sunshine Guojian Pharmaceutical Shanghai (including company regionals)

3s-guojian.com

See more website traffic and engagement information

Total visits to Sunshine Guojian Pharmaceutical Shanghai's top domains

Understand Sunshine Guojian Pharmaceutical Shanghai market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

3s-guojian.com13.6K

See more with Sales Intelligence

Avg. visit duration in Sunshine Guojian Pharmaceutical Shanghai's top domains

Analyze Sunshine Guojian Pharmaceutical Shanghai engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

3s-guojian.com00:05:24

See more with Sales Intelligence

Avg. pageviews on Sunshine Guojian Pharmaceutical Shanghai's top domains

See how Sunshine Guojian Pharmaceutical Shanghai keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

3s-guojian.com2.35

See more with Sales Intelligence

Sunshine Guojian Pharmaceutical Shanghai top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Sunshine Guojian Pharmaceutical Shanghai

These are the website technologies, by industry, used by Sunshine Guojian Pharmaceutical Shanghai top domains

Payment & Currencies (7)

Cart Functionality

Mobile (3)

Meta Viewport

Advertising (2)

PubMatic

Content Management System (2)

WordPress

More Technologies

5

See all

News & Signals from Sunshine Guojian Pharmaceutical Shanghai

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsVerseau Therapeutics, Inc. signs new client Sunshine Guojian Pharmaceutical Shanghai.Sunshine Guojian selects Verseau's vsig4-targeted antibody as the second partnered Macrophage Checkpoint modulator in immuno-oncology collaboration.